a significant trendp = 0.02
While TDR remained stable throughout the study period, clinically relevant resistance to first line drugs showed a significant trend to a decline (p = 0.02).
While TDR remained stable throughout the study period, clinically relevant resistance to first line drugs showed a significant trend to a decline (p = 0.02).
The fact that we have not found a decreasing trend in TDR (as of WHO list) indicates that this bias, if existing, is probably of small magnitude.